Physical Medicine & Rehabilitation, Pain Medicine · Sandy, UT
NPI
1487711123
Since 2007
Specialty
Physical Medicine & Rehabilitation, Pain Medicine
Code 2081P2900X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
11333 S 1000 E, Suite 102
Sandy, UT, 84094
Phone (801) 462-2205
Groups this clinician bills Medicare through
Medicare paid, 2024
$208K
7,892 services
Medicare patients, 2024
208
Average age 70
Drug cost, 2024
$342K
3,544 prescriptions
Company payments, 2025
$1,053
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael M Chen was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 1,091 times for 98 patients. In total Michael M Chen billed 7,892 services in 40 codes, and Medicare paid $208K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-01-06.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,091 | 98 | $0.10 | $112 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,005 | 85 | $0.75 | $758 |
| 99213 Office E&M - Established | Office | 809 | 140 | $57.21 | $46K |
| 99214 Office E&M - Established | Office | 522 | 171 | $88.22 | $46K |
| J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg | Office | 332 | 95 | $0.01 | $4.05 |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 180 | 35 | $5.05 | $909 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 175 | 12 | $0.09 | $15.82 |
| 77002 Imaging - Miscellaneous | Office | 152 | 61 | $79.87 | $12K |
| 20610 Joint Injection | Office | 144 | 61 | $45.55 | $6,559 |
| 80305 Drug Tests | Office | 105 | 80 | $12.16 | $1,277 |
| 99152 Anesthesia | Office | 57 | 31 | $36.50 | $2,081 |
| 64635 Destruction by Neurolytic Agent - Back | Office | 55 | 32 | $308.16 | $17K |
| 64636 Destruction by Neurolytic Agent - Back | Office | 53 | 31 | $174.97 | $9,273 |
| 64483 Nerve Block Injection - Back | Office | 45 | 28 | $211.00 | $9,495 |
| 64493 Nerve Block Injection - Back | Office | 41 | 22 | $183.95 | $7,542 |
By year: 2022 $199K for 6,192 services; 2023 $178K for 7,314 services; 2024 $208K for 7,892 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 105 | 80 | $12.16 | $1,277 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael M Chen prescribed most often to Medicare patients was Oxycodone Hcl, with 597 prescriptions and refills. In total Michael M Chen wrote 3,544 Medicare prescriptions that cost $342K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 597 | 597 | 83 | $14K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 371 | 371 | 56 | $16K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 303 | 303 | 52 | $10K |
| Morphine Sulfate Er Morphine Sulfate | 237 | 237 | 30 | $6,568 |
| Gabapentin Generic | 200 | 234 | 36 | $3,334 |
| Methocarbamol Generic | 134 | 138 | 32 | $2,442 |
| Tramadol Hcl Generic | 121 | 121 | 19 | $1,464 |
| Zolpidem Tartrate Generic | 100 | 112 | 11 | $918 |
| Buprenorphine Hcl Generic | 95 | 95 | 13 | $2,298 |
| Tizanidine Hcl Generic | 90 | 96 | 16 | $1,880 |
| Pregabalin Generic | 85 | 109 | 14 | $2,009 |
| Xtampza Er Oxycodone Myristate | 82 | 82 | 14 | $60K |
| Eszopiclone Generic | 70 | 70 | 11 | $1,341 |
| Cyclobenzaprine Hcl Generic | 70 | 74 | 17 | $763 |
| Celecoxib Generic | 69 | 80 | 13 | $1,007 |
Brand drugs: 276 claims; generic drugs: 3,268 claims; opioid claims: 1,860.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael M Chen $1,053 ($1,053 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $424.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 15 | $424 |
| Pfizer Inc. PFE | 11 | $252 |
| Collegium Pharmaceutical, Inc. COLL | 14 | $162 |
| Globus Medical, Inc. GMED | 2 | $54.34 |
| Boston Scientific Corporation BSX | 2 | $36.57 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $31.98 |
| Radius Health, Inc. | 2 | $29.34 |
| SPR Therapeutics, Inc | 1 | $25.55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $21.12 |
| Axsome Therapeutics, Inc. AXSM | 1 | $16.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.